Hayes Timothy 4

What Happened
Timothy Hayes, a director of Health In Tech, was granted 18,867 restricted shares of Class A common stock on July 8, 2026. The Form 4 reports the acquisition at $1.06 per share for a total value of $19,999. The award is coded as an acquisition/award (transaction code A) and, per the filing, the restricted shares vested on the grant date.

Key Details

• Transaction date: 2026-07-08; Filing date: 2026-07-10 (filed within the typical two-business-day window).
• Shares granted/acquired: 18,867 shares at $1.06 per share; total value $19,999.
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnote: F1 states these are restricted shares granted under the Health in Tech Equity Incentive Plan and that they vested as of the grant date.
• Remark: Exhibit 24 (Power of Attorney) attached to the filing.

Context
This was a compensation-related grant (restricted stock award) rather than an open-market purchase or sale. Restricted-share awards are common executive/director compensation and do not necessarily indicate the insider bought or sold stock for investment reasons. The immediate vesting (per footnote) means Hayes obtained full ownership of the shares on the grant date.